Innate Pharma files registration statement for proposed initial public offering in the United States

NEXT STORY
Oncology Venture presenterar positiva data på ESMO för prediktionsverktyget DRP vid 5-FU-behandling av kolorektalcancer
PREV STORY
Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innate Pharma presents new CD73 checkpoint inhibitor program

Novel antibodies identified that block the CD73 immune checkpoint for cancer immunotherapy; Strengthens Innate's ...

author_avatar
NASDAQ Market News

Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018

Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018 Amsterdam, ...

author_avatar
NASDAQ Market News

Apricus Biosciences Announces Sale of Ex-U.S. Vitaros Assets and Rights to Ferring Pharmaceuticals

Apricus Expects to Receive Approximately $12.7 Million from Ferring Apricus to Focus on Vitaros ...

author_avatar
NASDAQ Market News